A new drug tested on rodents may help prevent the development of type 2 diabetes and reverse its progression.
The drug blocks signalling from a protein, known as vascular endothelial growth factor B (VEGF-B), which then prevents fat from accumulating around the heart and other muscles.
Researchers found the cells in these tissues were then able to respond to insulin again, resulting in normal blood glucose levels.
Read more at The University of Melbourne